Cargando…

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity

Detalles Bibliográficos
Autor principal: Averbeck, Marcio Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747027/
https://www.ncbi.nlm.nih.gov/pubmed/36173410
http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02
_version_ 1784849499081932800
author Averbeck, Marcio Augusto
author_facet Averbeck, Marcio Augusto
author_sort Averbeck, Marcio Augusto
collection PubMed
description
format Online
Article
Text
id pubmed-9747027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-97470272022-12-16 Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity Averbeck, Marcio Augusto Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2022-11-01 /pmc/articles/PMC9747027/ /pubmed/36173410 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Update in Urology
Averbeck, Marcio Augusto
Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
title Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
title_full Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
title_fullStr Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
title_full_unstemmed Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
title_short Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
title_sort editorial comment: solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
topic Update in Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747027/
https://www.ncbi.nlm.nih.gov/pubmed/36173410
http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.02
work_keys_str_mv AT averbeckmarcioaugusto editorialcommentsolifenacintreatmentafterintradetrusorinjectionswithbotulinumtoxininpatientswithneurogenicdetrusoroveractivity